---
title: "Shanghai MicroPort MedBot Records Cumulative Order Volume for Core Products of Over 100 Units"
description: "Shanghai MicroPort MedBot (Group) recorded a cumulative order volume of over 100 units for the laparoscopic, orthopedic, and vascular interventional core products of the group for 2024, a Friday Hong "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/226142698.md"
published_at: "2025-01-24T10:50:19.000Z"
---

# Shanghai MicroPort MedBot Records Cumulative Order Volume for Core Products of Over 100 Units

> Shanghai MicroPort MedBot (Group) recorded a cumulative order volume of over 100 units for the laparoscopic, orthopedic, and vascular interventional core products of the group for 2024, a Friday Hong Kong bourse filing said. 39 orders were received for Toumai Laparoscopic Surgical Robot, while SkyWalker Orthopedic Surgical Robot saw an order volume of 25 units in 2024. Moreover, R-ONE Vascular Interventional Surgical Robot won purchase order bids from five top public hospitals in Shanghai, the filing said.

Shanghai MicroPort MedBot (Group) recorded a cumulative order volume of over 100 units for the laparoscopic, orthopedic, and vascular interventional core products of the group for 2024, a Friday Hong Kong bourse filing said.

39 orders were received for Toumai Laparoscopic Surgical Robot, while SkyWalker Orthopedic Surgical Robot saw an order volume of 25 units in 2024.

Moreover, R-ONE Vascular Interventional Surgical Robot won purchase order bids from five top public hospitals in Shanghai, the filing said.

### Related Stocks

- [00853.HK - MICROPORT](https://longbridge.com/en/quote/00853.HK.md)
- [ISRG.US - Intuitive Surgical](https://longbridge.com/en/quote/ISRG.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| MicroPort CardioFlow Merges with MicroPort CRM | MicroPort CardioFlow has merged with MicroPort CRM to create a comprehensive platform focused on structural heart, cardi | [Link](https://longbridge.com/en/news/275426231.md) |
| Golf-Woods won't rule out playing in this year's Masters | Tiger Woods, recovering from back surgery, has not ruled out competing in this year's Masters from April 9-12. Speaking  | [Link](https://longbridge.com/en/news/276159930.md) |
| Genxone Offer For Microbiome Sequencing Services Chosen As Most Favorable In Tender | Genxone SA :OFFER FOR MICROBIOME SEQUENCING SERVICES CHOSEN AS MOST FAVORABLE IN TENDER BY NATIONAL INSTITUTE OF GERIATR | [Link](https://longbridge.com/en/news/276140489.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/en/news/276016059.md) |
| AgelessRx Expands Access to Multi-Cancer Early Detection Solutions, in Honor of Cancer Prevention Month | AgelessRx is expanding access to its multi-cancer early detection solutions in honor of Cancer Prevention Month. This in | [Link](https://longbridge.com/en/news/276180967.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.